Panobinostat (Midatech)

帕比司他 (Midatech)

Report date: 2026/03/31 20:00:21

Base Information

Drug NamePanobinostat (Midatech)
Drug Alias NameMTX 110BDX-110
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsDiffuse midline gliomaMedulloblastomaDiffuse Intrinsic Pontine Glioma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiodexa Pharmaceuticals PLC
China Registration ClassN/A

Develop Information

Active CompaniesBiodexa Pharmaceuticals PLCFortovia Therapeutics IncThe University Of Texas Health Science Center At Houston +[4] 
Inactive CompaniesN/A
Active IndicationsDiffuse midline gliomaMedulloblastomaDiffuse Intrinsic Pontine Glioma +[4] 
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A